Bronstein, Gewirtz & Grossman LLC Urges Picard Medical, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Core Viewpoint - A class action lawsuit has been filed against Picard Medical, Inc. and certain officers for alleged violations of federal securities laws during the class period from September 2, 2025, to October 31, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Picard securities during the specified class period [2]. - Allegations include that the defendants issued false and misleading statements and failed to disclose material adverse facts [3]. - Specific claims involve a fraudulent stock promotion scheme, insider trading, and omissions regarding false rumors and artificial trading activity [8]. Group 2: Investor Participation - Investors affected by the alleged misconduct are encouraged to join the lawsuit and can request to be appointed as lead plaintiff until April 3, 2026 [3]. - Participation in any recovery does not require serving as lead plaintiff [3]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning they will only collect fees if the case is successful [4]. - The firm has a history of recovering hundreds of millions of dollars for investors in similar cases [5].